Literature DB >> 6311002

Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.

R Cleeland, E Squires.   

Abstract

An important advantage of antibiotic combinations which can be determined is the increase in spectrum of activity. Ad hoc combinations of amdinocillin with ampicillin, ticarcillin, piperacillin, azlocillin, cefazolin, cefamandole, cefoxitin, and moxalactam in ratios similar to those in serum after parenteral administration of normal dosages of these agents were tested in vitro against over 200 strains of bacteria, including Staphylococcus aureus, Streptococcus faecalis, representative genera of the Enterobacteriaceae, and Pseudomonas aeruginosa. Independent of amdinocillin's activity, it was possible to show marked enhancement of the spectrum of all the beta-lactam agents tested, except moxalactam, against members of the Enterobacteriaceae. Little or no enhancement or antagonism of activity was seen against gram-positive bacteria or P. aeruginosa. The enhancing activity of amdinocillin on three beta-lactam antibiotics, ampicillin, cefazolin, and cefoxitin, was also demonstrated in experimental mouse infections with gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311002     DOI: 10.1016/0002-9343(83)90090-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  The pharmacokinetics of mecillinam and pivmecillinam in pregnant and non-pregnant women.

Authors:  A Heikkilä; K Pyykkö; R Erkkola; E Iisalo
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

2.  Critical evaluation of amdinocillin disk susceptibility tests correlated with agar dilution tests.

Authors:  A L Barry
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

3.  Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.

Authors:  H D Isenberg; R C Tilton; A L Barry; G Beskid; R Cleeland; V Fallat; P R Murray; C Pierson; E Squires
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.